A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours
10.1186/s12885-020-07616-4
Saved in:
Main Authors: | , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-199287 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-1992872024-04-24T05:49:40Z A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours Ang, Y.L.E. Ho, G.F. Soo, R.A. Sundar, R. Tan, S.H. Yong, W.P. Ow, S.G.W. Lim, J.S.J. Chong, W.Q. Soe, P.P. Tai, B.C. Wang, L. Goh, B.C. Lee, S.-C. CANCER SCIENCE INSTITUTE OF SINGAPORE MEDICINE SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Advanced solid tumours Anti-angiogenic Docetaxel Short-course sunitinib Tumour vasculature 10.1186/s12885-020-07616-4 BMC Cancer 20 1 1118 2021-08-25T14:04:41Z 2021-08-25T14:04:41Z 2020 Article Ang, Y.L.E., Ho, G.F., Soo, R.A., Sundar, R., Tan, S.H., Yong, W.P., Ow, S.G.W., Lim, J.S.J., Chong, W.Q., Soe, P.P., Tai, B.C., Wang, L., Goh, B.C., Lee, S.-C. (2020). A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC Cancer 20 (1) : 1118. ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-020-07616-4 14712407 https://scholarbank.nus.edu.sg/handle/10635/199287 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ BioMed Central Ltd Scopus OA2020 |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
Advanced solid tumours Anti-angiogenic Docetaxel Short-course sunitinib Tumour vasculature |
spellingShingle |
Advanced solid tumours Anti-angiogenic Docetaxel Short-course sunitinib Tumour vasculature Ang, Y.L.E. Ho, G.F. Soo, R.A. Sundar, R. Tan, S.H. Yong, W.P. Ow, S.G.W. Lim, J.S.J. Chong, W.Q. Soe, P.P. Tai, B.C. Wang, L. Goh, B.C. Lee, S.-C. A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
description |
10.1186/s12885-020-07616-4 |
author2 |
CANCER SCIENCE INSTITUTE OF SINGAPORE |
author_facet |
CANCER SCIENCE INSTITUTE OF SINGAPORE Ang, Y.L.E. Ho, G.F. Soo, R.A. Sundar, R. Tan, S.H. Yong, W.P. Ow, S.G.W. Lim, J.S.J. Chong, W.Q. Soe, P.P. Tai, B.C. Wang, L. Goh, B.C. Lee, S.-C. |
format |
Article |
author |
Ang, Y.L.E. Ho, G.F. Soo, R.A. Sundar, R. Tan, S.H. Yong, W.P. Ow, S.G.W. Lim, J.S.J. Chong, W.Q. Soe, P.P. Tai, B.C. Wang, L. Goh, B.C. Lee, S.-C. |
author_sort |
Ang, Y.L.E. |
title |
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
title_short |
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
title_full |
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
title_fullStr |
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
title_full_unstemmed |
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
title_sort |
randomized phase ii trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours |
publisher |
BioMed Central Ltd |
publishDate |
2021 |
url |
https://scholarbank.nus.edu.sg/handle/10635/199287 |
_version_ |
1800914980206280704 |